The effect of dietary methionine (Met) on the biopotency of selenium (Se) from selenite and Selenomethionine (Se-Met) was studied in rats fed a 30% torula yeast-based diet containing 0.24% Met and less than 0.02 ppm Se. Biopotency was quantitated by assaying liver, plasma and heart for the glutathione peroxidase (GSH-Px) increase elicited by a given level of Se fed for 1 week to Se-deficient rats. At dietary Se levels up to 0.5 ppm Se, the level of dietary Met supplementation did not alter selenite biopotency. In contrast, dietary Met supplementation increased the biopotency of Se-Met. With basal Met intakes, the biopotency of Se-Met was 25% that of selenite below 0.5 ppm Se. The addition of 0.4% Met to the diet made Se-Met biopotency equivalent to selenite biopotency in one experiment, but in a second experiment with younger, faster growing rats, 0.4% Met did not completely restore the biopotency of SeMet. These results indicate that low dietary Met decreases the biopotency of SeMet but not of selenite. Altered Se metabolism at suboptimal dietary Met may occur because more Se-Met is incorporated into protein and thus less Se is avail able for GSH-Px synthesis. These results suggest that adequate dietary Met is required for optimal utilization of the Se in feedstuffs of plant origin, as Se-Met is presumably a major form of plant selenium.
Glutathione peroxidase (glutathione: (8) . However, Se-Met is incorporated into H2O2 oxidoreductase, EC 1.11.1.9) was general body proteins by the same pathshown by Rotruck and co-workers ( 1) to be ways as methionine [Met] (9) and the level a selenoenzyme. Tissue glutathione per-of dietary Met affects the rate of Met oxidase (GSH-Px) activity falls dramatioxidation (10) . Thus the biological pocally in animals fed a selenium (Se) tency of Se-Met might be altered by the deficient diet and rises during Se re-dietary Met level whereas that of selenite pletion (2, 3) . Many, if not all, of the should not be affected, defects caused by Se deficiency can Experiments were conducted to test logically be explained by lack of tissue whether the level of dietary Met affected GSH-Px (2, 4, 5) .
the biopotency of Se-Met and selenite. Schwarz and Foltz (6) reported that sodium selenite and Selenomethionine~~77 .
,,,.
Received for publication 17 Se-deflcient rats were resupplemented with Se for 1 week and the tissue GSH-Px activity response was measured to deter mine biopotency.
MATERIALS AND METHODS
In all experiments male weanling rats, 21 days old, of the Holtzman strain were housed in individual hanging wire mesh cages. Diet and water were provided ad libitum except where noted. The basal diet was that of Schwarz (11) as modified by Hafeman and Hoekstra (12) . It was composed of 30% torula yeast (St. Regis Paper Co., Rhinelander, WI), 59% su crose, 5% lard, 5% mineral mix, 0.9% vitamin mix and 0.1% choline chloride as described by Hafeman and Hoekstra (12) . The basal diet also contained less than 0.02 ppm Se (0.013 Â± 0.001 ppm Se for 9 determinations) as determined by fluorometric analysis (13) and contained by calculation 0.24% Met and 0.18% cystine resulting in a diet deficient in the sulfur amino acids. DL-Methionine (United State Biochemical Corp., Cleve land, OH), when supplemented, was added at the expense of sucrose. The Met itself had a Se content of 0.02 ppm Se so Met supplementation had a negligible effect on the Se content of the diet. All the diets were supplemented with 100 lU/kg of a/Z-rac-a-tocopheryl acetate (ICN Phar maceuticals Inc., Cleveland, OH) to pre vent liver necrosis. Experiment 1. An experiment was con ducted to study the rate of response of tissue GSH-Px to dietary Se repletion for 0-10 days in the rat. Weanling rats were fed the basal diet supplemented with 0.3% Met. After 21 weeks, the Se-deficient rats were randomly segregated into eight groups. The rats were fed the diet supplemented with 0.5 ppm Se as Na2SeO3on a staggered schedule so that at the time of death the groups had been supplemented with Se for 0, 1,2, 3, 4, 5, 7, and 10 days. The rats were fasted over night prior to the start of supplementation to insure that each rat began eating the new diet immediately. All rats were killed on the same day. Erythrocytes, plasma and livers were analyzed for GSH-Px as described for experiment 2, except that the livers were perfused with 0.15 MKC1 to remove erythrocytes, and were stored on ice until analysis.
Experiment 2. The effect of three levels of dietary Met on the biopotency of selenomethionine and selenite in rats was studied in this experiment. Ninety rats were fed the basal diet supplemented with 0.3% Met. After 74 days [approxi mately 10 times the half-life of liver GSH-Px (2)] the rats were divided into 15 groups (six rats/group) of equal average body weight, and five groups each were fed the basal diet supplemented with 0, 0.4 or 0.9% Met. Rats adapt to a change in dietary Met in 3-4 days (14) , so a 7-day period was used to insure adaptation. These levels of Met resulted in diets providing roughly 50,100 and 200% of the sulfur amino acid requirement of the rat (15) .
The 7-day Met adaptation period was followed by 7 days of dietary Se repletion. The rats were fasted overnight prior to the start of Se repletion. At each of the three dietary Met levels, Se was supplemented at Oppm Se, and at 0.2 and 0.5 ppm Se as DL-selenomethionine (Sigma Chemical Co., St. Louis, MO) or Na2SeO3 (ICN K & K Laboratories Inc., Cleveland, OH). Stock solutions of freshly prepared selenite and Se-Met in water were ana lyzed to confirm the calculated Se con centrations. Appropriate amounts were diluted in 95% ethanol and added to the basal diet; the Se content of the diets was confirmed fluorometrically.
At the end of the Se repletion period, each rat was anesthetized with ether, blood was drawn by cardiac puncture with a heparinized syringe, and the liver and heart were weighed and stored at -20Â°for later analysis. Whole blood hematocrits were determined and hemo globin concentration was measured by the cyanomethemoglobin method (16) . Plasma was separated from the erythro cytes by centrifugation (1,000 x g x 15 minutes) the same day the rats were killed, and analyzed for GSH-Px activity and pro tein. White cells were removed from packed erythrocytes by gentle suction as white cells contain high levels of GSH- Px activity (17) . The erythrocytes were resuspended in saline-phosphate buffer (pH 7.4), diluted and hemolyzed in water, and assayed for GSH-Px and hemoglobin. The livers were homogenized in 3 vol umes of water with five strokes of a teflon-glass homogenizer; the hearts were homogenized for 30 seconds in 9 volumes of water using a Polytron homogenizer (Brinkmann Instruments, Westbury, NY). GSH-Px activity was assayed by the coupled assay procedure (18) using H2O2 so only the Se-containing enzyme was measured (19) . Protein was determined by the method of Lowry et al. (20) .
Experiment 3. To confirm and extend the observations of experiment 2, the ef fect of two levels of dietary Met on the biopotency of Se-Met and selenite at five levels of Se supplementation was ex amined. Weaning rats were fed the Sedeficient diet supplemented with 0.4% Met for 32 days. The rats were then weighed, and the six lightest and four heaviest rats were discarded, leaving 132 rats for the experiment. These rats were segregated randomly into 22 groups of six rats each and fed the basal diet, half with 0% and half with 0.4% supplemental Met. After 7 days of Met adaptation, the rats were fasted overnight and then Se was supplemented for 7 days. At each level of Met, Se was supplemented at 0 ppm and at 0.05, 0.1, 0.2, 0.5 and 1.0 ppm Se as either Se-Met or selenite. Tissues were analyzed as described for experiment 2.
The results were analyzed using lin ear regression, analysis of variance or Duncan's multiple-range test, as indi cated (21) .
RESULTS

Experiment 1. Repletion of 0.5 ppm
Se as selenite to Se-deficient rats caused a linear increase with time in the GSHPx activity of liver and plasma during the 1-10 days of repletion. Linear regression analysis (21) indicated that liver GSH-Px increased by 0.050 EU/mg protein per day during repletion (r = 0.94, P < 0.001) and plasma GSH-Px increased by 0.0083 EU/ mg protein per day (r = 0.99), P < 0.001). After 10 days of repletion, liver and plasma GSH-Px activities were 70 and 100%, respectively, of levels measured in rats maintained since weaning on a diet containing 0.2 ppm Se as selenite. Erythrocyte GSH-Px activity was less responsive to Se repletion (r = 0.70, P < 0.01) and reached only 30% of the levels measured in rats fed 0.2 ppm Se continuously. This slow response was due to lack of de novo enzyme synthesis in mature erythrocytes and the 60-day lifespan of the erythrocyte (2, 22) . Hemolysis during blood sampling and handling, as determined by measurement of hemo globin in the plasma, could only account for 1-2% of the plasma GSH-Px activity after 3 or more days of Se repletion. Thus GSH-Px was present in plasma during repletion. The length of Se repletion had no effect on hematocrit, whole blood hemoglobin, plasma protein or liver pro tein (all r < 0.42).
The linear response of plasma and liver GSH-Px to length of Se repletion indi cates synthesis of a constant quantity of GSH-Px per day during the first 10 days of dietary Se repletion with selenite. To stay within this time span, a 7-day Se repletion period was chosen for the next experiments.
Experiment 2. Supplemental Dietary Se (ppm) Met. Se-Met supplemented at 0.2 ppm Se resulted in liver GSH-Px activity with basal dietary Met that was 25% of the activity observed with 0.4 or 0.9% sup plemental Met. Less dramatic differences in Se-Met biopotency due to the level of dietary Met persisted at 0.5 ppm Se. In this experiment liver GSH-Px activity in rats not supplemented with Se was sig nificantly reduced in animals fed the basal Met diet for 14 days as compared to rats supplemented with 0.4 or 0.9% Met.
The pattern of plasma GSH-Px re sponse to the dietary treatments was similar to that of liver ( fig. 2) . The GSHPx activities suggested that the plasma GSH-Px dose-response curves had plateaued by 0. biopotency; with 0.5 ppm dietary Se, Se-Met biopotency was no longer sig nificantly different from selenite bio potency.
The GSH-Px dose-response curves for heart were also similar to those of liver and plasma ( fig. 3 ). These curves did not suggest a response plateau by 0.5 ppm dietary Se in heart. The level of dietary Met had no effect on the biopotency of selenite at either Se intake. Supplemental dietary Met increased the biopotency of Se-Met; with Se-Met supplementation at either 0.2 or 0.5 ppm Se, the GSH-Px activity with 0.4% supplemental Met was significantly greater than that with basal dietary Met.
Erythrocyte GSH-Px activities (not shown) were not significantly affected by dietary Met intake for either selenite or Se-Met. Se-Met biopotency was sig nificantly lower than selenite biopotency only in rats not supplemented with Met.
Experiment 3. The GSH-Px dose-re sponse curves for liver, plasma and heart were sigmoidal when determined for more levels of Se supplementation than used in experiment 2 (figs. [4] [5] [6] . In liver, the GSH-Px dose-response curves had essentially plateaued by 0.5 ppm Se 3 Mean Â±SEM. Each group consisted of six rats. Means at the same level of dietary Se were compared. Means within a line not followed by a common superscript are significantly different (P < 0.05) according to Duncan's multiple-range test (21) .
( fig. 4) . Table 1 shows the same data as an example of the statistically significant differences observed. Dietary Met had little or no effect on selenite biopotency below 1.0 ppm Se. In contrast, Se-Met biopotency was significantly increased at 0.2 and 0.5 ppm Se when the diet was supplemented with 0.4% Met as compared to basal Met. When the diet was not supple mented with Met, the Se-Met biopotency was significantly lower than selenite bio potency at dietary levels up to 0.5 ppm Se; with 0.4% dietary Met supplementa tion, Se-Met was still less biopotent than selenite at dietary Se levels up to 0.2 ppm. At 1.0 ppm dietary Se, selenite bio potency with the basal Met intake was significantly lower than with 0.4% Met intake, perhaps due to increased selenite toxicity when dietary Met is subop timal (23) .
The plasma GSH-Px dose-response curves were generally similar to those of liver ( fig. 5) In this experiment, the depressed sel enite biopotency observed in plasma when dietary Met was suboptimal may have occurred because these rats were younger and faster growing than in ex periment 2, and therefore these rats may have had a higher sulfur amino acid re quirement.
Other experiments in our laboratory have indicated that 0.9% sup plemental Met promotes growth above 0.4% Met with this Se-deficient, torula yeast-based diet.3 Dietary amino acid imbalance has different effects on re tained and secreted liver proteins (24) , and protein synthesis can be inhibited by intermediates of selenite reduction (25) . A combination of these effects may have reduced the GSH-Px response elicited by selenite in plasma but not in liver when the diet was deficient in Met.
The GSH-Px dose-response curves for heart plateaued at 0.5 ppm Se for sel enite and appeared to plateau between Erythrocyte GSH-Px activities (not shown) were not significantly affected by dietary Met for either selenite or Se-Met. However in both experiments 2 and 3, supplemental Met nominally increased erythrocyte GSH-Px activity when SeMet was supplemented and nominally decreased GSH-Px activity when selenite was supplemented. Three-way analysis of variance of the erythrocyte data in dicated a significant Met x form-of-Se interaction (21), substantiating these ob servations.
In experiment 3, the biopotency of SeMet was significantly lower than that of selenite at 0.1, 0.2 and 0.5 ppm Se in liver and heart when the diet was not supplemented with Met. With the addi tion of 0.4% Met, Se-Met biopotency increased, but Se-Met biopotency was still significantly lower than selenite at 0.1 and 0.2 ppm Se in this experiment. These rats were younger than those of experiment 2 and may have had a sulfur amino acid requirement not met by 0.4% Met supplementation.
The dashed horizontal lines in figures 1-6 correspond to half the maximal increase in GSH-Px activity elicited by selenite at 0.4% Met. The level of dietary Se necessary to yield this GSH-Px re-
Supplemental
Dietary Se (ppm) sponse, analogous to an enzyme substrate Kra,was graphically determined for each treatment. We chose to compare Se treat ments using this method because the average of a treatment's effectiveness relative to selenite at several Se supple mentation levels does not accurately de scribe the response curve. Instead, these biopotency (Bm)values correspond to the levels of dietary Se for each treatment necessary to develop the same effective concentration of Se in the tissue available for GSH-Px synthesis. The Bmvalues thus take into account the competition by several pathways for the Se.
Comparison of these dietary Se levels indicates that the biopotency of Se-Met and selenite differed (table 2). The Bm values are inversely correlated with the Se biopotency of Se compounds; a small Bmvalue indicates a high biopotency of that Se compound. The Bmvalues of sel enite, as determined for a given tissue and experiment, were essentially unaltered by dietary Met supplementation, except for plasma in experiment 3 as discussed above. In contrast, the Bm values of SeMet, as determined for a given tissue and experiment, decreased dramatically as dietary Met was increased from basal to 0.4% supplementary Met. When the diet was supplemented with 0.4% Met, the level of Se necessary to increase GSH-Px activity to the half-maximal level in liver, plasma and heart was 56, 68 and 72% lower than when no Met was supple mented in experiment 2, and 55, 46 and 69% lower, respectively, in experiment 3. The Bmvalue of Se-Met for plasma was also decreased by 0.9% as compared to 0.4% Met supplementation.
Bmvalues clearly indicate that dietary Met had a dramatic effect on Se-Met bio- 1The biopotency (Bm) value for each treatment is the level of dietary Se supplementation that resulted in tissue glutathione peroxidase (GSH-Px) activity equal to half the maximal response elicited by selenite at 0.4% Met. These values were determined graphically from figures 1-6. potency but a negligible effect on selenite biopotency. Furthermore, the Bm values for selenite at 0.4% dietary Met suggest that the plasma GSH-Px response reached the half-maximal level at the lowest level of Se supplementation, followed by liver and then heart. This order may simply reflect the relative rates of general protein synthesis in these tissues, or it might suggest the relative tissue saturation pattern of GSH-Px synthesis. No dif ferences in feed consumption between treatment groups were observed in any experiment.
Analysis of variance (21) indicated that level of Se supplementa tion or form of Se did not have an effect on weight gain, whereas Met supplemen tation significantly increased weight gain. Heart and plasma protein concentration (mg protein/g tissue) was not affected by treatment in any experiment. Analysis of variance indicated significant but small (5% or less) variations in liver protein concentration. These effects did not alter the treatment differences in GSH-Px activity.
DISCUSSION
The biopotency of Se-Metâ€"that is, the ability of dietary Se-Met to promote GSH-Px synthesisâ€"in liver, heart and plas ma was reduced in rats fed a low Met as compared to adequate Met diet. In ex periment 2 the addition of 0.4 and 0.9% Met to the diet raised biopotency of SeMet to values equivalent to those of sel enite; in experiment 3 with younger rats, 0.4% supplemental Met effectively raised Se-Met biopotency but not to levels equal to those of selenite. Differences in Se-Met and selenite biopotency have sometimes been re ported by other workers. In chicks SeMet was 4 times as effective as selenite for the prevention of pancreatic fibrosis (26) , but Se-Met was less effective than selenite for the prevention of exudative diathesis (27) . Recent reports have dem onstrated that vitamin B-6 deficiency in rats impairs the ability of Se-Met but not selenite to restore GSH-Px activity, pre sumably because of reduced activity of pyridoxal-dependent enzymes necessary for Se-Met metabolism (28).
Schwarz and Foltz (6) reported that SeMet and selenite had equal ability to prevent liver necrosis in rats fed the 30% torula yeast-based diet which was suboptimal in Met and cystine. The levels of supplemental Se (0.02-0.04 ppm Se) used by these workers are at the low end of the dose-response curve observed in our ex periments (fig. 4) . The small differences in Se-Met and selenite biopotency we observed at 0.05 ppm Se may not have been distinguishable using death due to liver necrosis as the biopotency assay. Pierce and Tappel (7) found equal ability of Se-Met and selenite to induce GSH-Px activity when Se was given as a single oral dose (300 Â¿tg/90g rat) which would be in excess of 15-20 ppm dietary Se if fed for 1 day, and thus in the plateau region of the GSH-Px dose-response curves observed in our experiments ( fig.  4 ). Below this plateau in our experiments, less Se from Se-Met was available for GSH-Px synthesis.
The plateaus in the GSH-Px activity dose-response curves indicate that Se was no longer limiting for GSH-Px synthesis at high levels of dietary Se, and so little or no difference between the biopotency of selenite and Se-Met was observed. The dietary Se levels that resulted in maximal rates of GSH-Px synthesis are much higher than dietary Se levels that allow maximal growth or maintain GSH-Px activity (2); thus, these Se levels should not be used as estimates of the Se requirement of the rat.
Metabolic studies with rats show that the intestinal absorption of selenite and Se-Met is essentially equivalent (92% for selenite and 96% for Se-Met) and wholebody retention indicates that excretion of absorbed selenite Se is initially greater than Se-Met Se (29) . Se-Met and Met compete for the same intestinal trans port system in the hamster (30) , and pre sumably the rat. Thus, the observed variations in selenite and Se-Met bio potency cannot be explained by absorp tion and excretion differences of these Se compounds, and the effect of dietary Met on Se-Met biopotency cannot be ex plained by effects on Se-Met absorption.
Se-Met readily acylates Met-tRNA and is incorporated into rat liver protein in place of Met (31, 9) . When Metis limiting, a greater percentage of the Se-Met will be incorporated into general body pro teins where, at least in the short term, it will be unavailable for GSH-Px synthesis in the growing rat. Selenite is not con verted to Se-Met in non-ruminants (32, 33) and so is not sequestered in general body proteins, especially in muscle pro teins (34) . Thus, reports that sulfur amino acids offer protection against liver ne crosis (11, 35) may have been due in part to improved availability of the Se-Met in torula yeast. However, additional Met also raises hepatic GSH levels.4 A higher GSH concentration increases the ap parent Vmaxof GSH-Px (36) and so Met may protect rats against liver necrosis in this manner. These experiments have demonstrated that Se-Met is less biopotent than selenite in rats fed a diet suboptimal in Met, especially at dietary Se levels near the Se requirement (0.05-0.20 ppm Se). The biopotency of Se in non-ruminant live stock diets may be reduced because Met is commonly a limiting amino acid in practical diets, and because Se-Met is presumably a major form of Se in plant feedstuffs (37, 38) . Similarly, tissue Se levels may not adequately measure the physiological Se status of the body be cause Se-Met is incorporated into general body proteins. This tissue Se-Met may possibly serve as an important longterm source of Se as body proteins turn over.
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